TRP
TISSUE REP FPO [TRP]
Healthcare · ASX Small Cap
$0.1550 +1.6%
Updated 26 Mar 2026 · Scores refresh every scan
Score Breakdown
Technical75
Catalyst50
Sentiment50
Fundamental54
Momentum52
Risk Gate42
Get alerts when TRP's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- MACD momentum is picking up steam
- Stochastic just turned bullish from a low level — early reversal sign
- Volume surging at 2.2x normal while price climbs — real buying conviction behind this move
- Volatility is contracting — like a spring being compressed, breakouts often follow
- Adequate cash runway (6 quarters)
- 4C filed 2026-01-30
- Low P/S ratio (2.7x)
- Strong revenue growth (+114%)
- EPS estimates revised downward (-10pts)
- Near 52-week low (0% of range)
- Micro-cap ($5-20M) - high risk
- Sentiment is mixed — no strong consensus either way
- Revenue growing at +114% — the top line is moving in the right direction
- Altman Z-Score distress zone (1.35 < 1.81, low-confidence approx)
- RBA hiking (-3pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Below the 200-day average — the long-term trend is still working against it
- Deeply negative margins (-114%)
- Not enough chatter to gauge sentiment — defaulting to neutral
- The bigger volume days are the down days — volume-weighted momentum is negative (-7.16%/day)
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about TRP
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Notification of cessation of securities - TRP
NONE Notification regarding unquoted securities - TRP
NONE Appendix 4D and Half Year Report to 31 December 2025
LOW Quarterly Activities/Appendix 4C Cash Flow Report
Recent ASX Announcements
| 2026-03-03 | Notification of cessation of securities - TRP |
| 2026-02-27 | Notification regarding unquoted securities - TRP |
| 2026-02-27 | Appendix 4D and Half Year Report to 31 December 2025 PRICE SENSITIVE |
| 2026-01-30 | Quarterly Activities/Appendix 4C Cash Flow Report PRICE SENSITIVE |
Key Metrics
$9.1M
Market Cap
41K
Avg Volume
2.2x
Vol Ratio
$0.15 — $0.48
52-Week Range
N/A
Short Interest
6 qtrs
Cash Runway
-28.1%
ROE
-113.9%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 57% |
| L | Leader vs Laggard | laggard | RS: -13 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #55 of 117 · Sector avg: 46
View all Healthcare signals →Track TRP and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required